Molecular Mechanism of Crataegi Folium and Alisma Rhizoma in the Treatment of Dyslipidemia Based on Network Pharmacology and Molecular Docking

Table 1

Active compounds of SZHP.

MOL ID	Active compound	OB (%)	DL	Drug	Serial no.
MOL000359	Sitosterol	36.91390583	0.7512	SZ, ZX	A1
MOL000354	Isorhamnetin	49.60437705	0.306	SZ	SZ1
MOL000422	Kaempferol	41.88224954	0.24066	SZ	SZ3
MOL000449	Stigmasterol	43.82985158	0.75665	SZ	SZ4
MOL000073	Ent-Epicatechin	48.95984114	0.24162	SZ	SZ5
MOL000098	Quercetin	46.43334812	0.27525	SZ	SZ6
MOL000831	Alisol B monoacetate	35.57623621	0.80629	ZX	ZX2
MOL000849	16β-Methoxyalisol B monoacetate	32.42724106	0.7679	ZX	ZX3
MOL000853	Alisol B	36.76038067	0.81993	ZX	ZX4
MOL000856	Alisol C monoacetate	33.06358947	0.82763	ZX	ZX5
MOL002464	1-Monolinolein	37.17662836	0.30249	ZX	ZX6
MOL000862	[(1S, 3R)-1-[(2R)-3, 3-Dimethyloxiran-2-yl]-3-[(5R, 8S, 9S, 10S, 11S, 14R)-11-hydroxy-4, 4, 8, 10, 14-pentamethyl-3-oxo-1, 2, 5, 6, 7, 9, 11, 12, 15, 16-decahydrocyclopenta [a] phenanthren-17-yl] butyl] acetate	35.58	0.81	ZX	ZX7